跳至主要内容
临床试验/NCT06803862
NCT06803862进行中(未招募)不适用

RegiStry Of the multiFaceted medIcal cenTer

National Medical Research Center for Therapy and Preventive Medicine4 个研究点 分布在 2 个国家目标入组 21,783 人开始时间: 2021年1月1日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
21,783
试验地点
4
主要终点
All-cause mortality

研究概览

简要总结

This study is a prospective medical registry (the SOFIT Registry) that enrolls all patients hospitalized in various departments of the Tula Regional Clinical Hospital in 2021.

The primary objective of the study is to analyze demographic, clinical and anamnestic characteristics of patients, history of COVID-19, the structure of multimorbidity, the quality of diagnostics and treatment, as well as short-term and long-term outcomes. As a part of this project a five-year follow-up is planned. The information will be obtained from Medical Information System resource of the hospital and regional and federal electronic databases.

详细描述

Nowadays in the Russian Federation chronic non-communicable diseases are one of the most common causes of hospitalization and also a concomitant pathology in the majority of patients undergoing hospital treatment in departments of various profiles. The creation of a prospective medical registry is an informative method for a comprehensive assessment of the characteristics of patients, including demographic, clinical and anamnestic data, the structure of multimorbidity, the quality of diagnostics and treatment as well as an assessment of short-term and long-term outcomes.

The aim of this project is to create a prospective registry of a multifaceted medical center (SOFIT), including all patients hospitalized in various departments of the hospital.

Patients admitted to the Tula Regional Clinical Hospital from 01.01.2021 to 31.12.2021 were retrospectively enrolled into this study. The information from electronic medical records was obtained using the Medical Information System resource of the hospital.

At the first stage, it is planned to analyze the age and gender characteristics of patients, the proportion of cases of cardiovascular and chronic non-cardiac diseases and their combinations, the frequency of a history of COVID-19, laboratory and instrumental data, cardiovascular pharmacotherapy prescribed in the hospital and hospital mortality. The obtained data will be compared in the cardiologic, therapeutic and other departments.

At the second stage, the prospective follow-up will be carried out up to 5 years after the reference hospitalization. It will involve the evaluation of long-term outcomes, such as all-cause mortality, cardiovascular events (cardiovascular death, nonfatal myocardial infarction, nonfatal cerebral stroke, hospitalizations and surgical interventions for cardiovascular diseases), cases of COVID-19 based on patient's medical records. The information about cases of death (date and cause of death, place of death registration), cardiovascular events during follow-up will be obtained from the regional database of death cases in population of the Tula region and from other regional electronic databases. The information about cases of COVID-19 will be obtained from the Russian Federal Registry of COVID-19.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients hospitalized to the Tula Regional Clinical Hospital from 01.01.2021 to 31.12.
  • Age 18 years and older.
  • Permanent residency in Tula city and Tula region.

排除标准

  • 1. Permanent residency outside of Tula city and Tula region.

结局指标

主要结局

All-cause mortality

时间窗: 5 years after inclusion

Time to all-cause mortality, cardiovascular mortality, nonfatal myocardial infarction, nonfatal cerebral stroke, coronary/carotid revascularization

时间窗: from discharge up to 5 years after reference hospitalization

次要结局

  • Time to composite endpoint (nonfatal myocardial infarction or nonfatal cerebral stroke or coronary/carotid revascularization)(from discharge up to 5 years after reference hospitalization)
  • Proportion of patients with nonfatal myocardial infarction(from discharge up to 5 years after reference hospitalization)
  • Proportion of patients with nonfatal cerebral stroke(from discharge up to 5 years after reference hospitalization)
  • Proportion of patients with cases of COVID-19 during follow-up(from discharge up to 5 years after reference hospitalization)
  • Hospitalization due to cardiovascular disease, proportion of patients with hospitalization due to cardiovascular disease(from discharge up to 5 years after reference hospitalization)
  • Hospitalization due to COVID-19, proportion of patients with hospitalization due to COVID-19(from discharge up to 5 years after reference hospitalization)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验